Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population

Drug Metabolism and Disposition

Volumn 35, Issue 4, 2007, Pages 667-675

  Kang, Ho Jin ^a   Song, Im Sook ^a   Ho, Jung Shin ^a   Kim, Woo Young ^a   Lee, Choong Hee ^a   Shim, Joo Cheol ^a   Zhou, Hong Hao ^b   Sang, Seop Lee ^a   Shin, Jae Gook ^a  

^a Inje University College of Medicine   (South Korea)

^b Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CARBON 14; METHYL 4 PHENYLPYRIDINIUM ACETIC ACID; ORGANIC CATION TRANSPORTER; TETRYLAMMONIUM; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CELL LINE; CHINA; DOGS; GENE FREQUENCY; GENOTYPE; HUMANS; KINETICS; KOREA; LINKAGE DISEQUILIBRIUM; MICROINJECTIONS; MOLECULAR SEQUENCE DATA; OOCYTES; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TETRAETHYLAMMONIUM; TRANSFECTION; VIETNAM; XENOPUS LAEVIS;

EID: 34047123147     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.013581     Document Type: Article

References (29)

1. Barrerr JC, Fry B, Maller J, and Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 15:263-265.
2. Burckhardt G and Wolff NA (2000) Structure of renal organic anion and cation transporters. Am J Physiol 278:F853-F866.
3. Fujita T, Urban TJ, Leabman MK, Fujita K, and Giacomini KM (2006) Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95:25-36.
4. Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M, Kamakura S, Kitakaze M, Tomoike H, Saito Y, et al. (2004) Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab Pharmacokinet 19:239-244.
5. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. (2002) The structure of haplotype blocks in the human genome. Science (Wash DC) 296:2225-2229.
6. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Land F, Busch AE, and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
7. Jonker JW and Schinkel AH (2004) Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9.
8. Jonker JW, Wagenaar E, Mol CA, Buitelaar M, Koepsell H, Smit JW, and Schinkel AH (2001) Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter1 (Oct1 [Slc22a1]) gene. Mol Cell Biol 21:5471-5477.
9. Jonker JW, Wagenaar E, Van Eiji S, and Schinkel AH (2003) Deficiency in the organic cation transporters 1 and 2 (Oct1 and Oct2 [Slc22a1 and Slc22a2]) in mice abolishes the renal secretion of organic cations. Mol Cell Biol 23:7902-7908.
10. Kang HJ, Lee SS, Lee CH, Shim JC, Shin HJ, Liu KH, Yoo MA, and Shin JG (2006) Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters. Drug Metab Dispos 34:1145-1151.
11. Kerb R, Brinkmann U, Chatskaia N, Gorbunov D, Gorboulev V, Mornhinweg E, Keil A, Eichelbaum M, and Koepsell H (2002) Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Phamacogenetics 12: 591-595.
12. Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, and Inui K (2005) (2005) Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet 20:379-386.
13. Koepsell H (1999) Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 60:243-266.
14. Kusuhara H, Sekime T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kamai Y, and Endou H (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675-13680.
15. Lazar A, Grundemann D, Berkels R, Taubert D, Zimmermann T, and Schomig E (2003) Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3). J Hum Genet 48:226-230.
16. Leabman MK and Giacomini KM (2003) Estimating the contribution of genes and environment to variation in renal drug clearance. Phamacogenetics 13:581-584.
17. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, De Young J, Taylor T, Clark AG, Herskowitz I, et al. (2002) Pharmacogenetics of Membrane Transporters investigators: polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 12:395-405.
18. Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheng C, Gonzalez FJ, and Klaassen CD (2006) Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1a. Biochem Pharmacol 72:512-522.
19. Popp C, Gorboulev V, Müller TD, Gorbunov D, Shatskaya N, and Koepsell H (2005) Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol Pharmacol 67:1600-1611.
20. Saborowski M, Kullak-Ublick GA, and Eloranta JJ (2006) The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4α. J Pharmacol Exp Ther 317:778-785.
21. Sakata T, Anzai N, Shin HJ, Noshiro R, Hirata T, Yokoyama H, Kanai Y, and Endou H (2004) Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun 16:789-793.
22. Shu Y, Bello CL, Mangravite LM, Feng B, and Giacomini KM (2001) Functional characterization and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells. J Pharmacol Exp Ther 299:392-398.
23. Shu Y, Leabman MK, Feng B, Mangrabite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, De Young J, Carlson E, et al. (2003) Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 100:5902-5907.
24. Takeuchi A, Motohashi H, Okuda M, and Inui K (2003) Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. Drug Metab Pharmacokinet 18:409-412.
25. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, and Sugiyama Y (2002) Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J Pharmacol Exp Ther 302:510-515.
26. Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, and Sugiyama Y (2003) Involvement of organic cation transporter 1 in lactic acidosis caused by metformin. Mol Pharmacol 63:844-848.
27. Yin OO, Tomlinson B, and Chow MS (2006) Variability in renal clearance of substrates for renal transporters in Chinese subjects. J Clin Pharmcol 46:157-163.
28. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, and Giacomini KM (1997) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913-921.
29. Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C, and Barlow DP (2001) Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 21:4188-4196.